Literature DB >> 8384630

Humoral immune response to human cytomegalovirus DNA polymerase.

M P Landini1, T Lazzarotto, P F Ertl.   

Abstract

In this work, we show that antibodies to baculovirus recombinant DNA polymerase of human cytomegalovirus are present in human sera during natural infection. Specific antibody was found to be of the immunoglobulin G class, produced at low titers only for a short period of time at the beginning of acute infection and not detectable in sera from patients with a convalescent or a latent phase of infection. These results were compared with those obtained with procaryotically expressed p52, the polymerase accessory protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384630      PMCID: PMC262854          DOI: 10.1128/jcm.31.3.724-726.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Immunoaffinity purification of a 72K early antigen of human cytomegalovirus: analysis of humoral and cell-mediated immunity to the purified polypeptide.

Authors:  B Rodgers; L Borysiewicz; J Mundin; S Graham; P Sissons
Journal:  J Gen Virol       Date:  1987-09       Impact factor: 3.891

2.  High level expression of DNA polymerases from herpesviruses.

Authors:  P F Ertl; M S Thomas; K L Powell
Journal:  J Gen Virol       Date:  1991-07       Impact factor: 3.891

Review 3.  Progress in vaccine development for prevention of human cytomegalovirus infection.

Authors:  E Gönczöl; S Plotkin
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

Review 4.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

5.  Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting.

Authors:  M P Landini; M C Re; G Mirolo; B Baldassarri; M La Placa
Journal:  J Med Virol       Date:  1985-12       Impact factor: 2.327

Review 6.  Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease.

Authors:  D R Snydman
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

7.  Identification and preliminary use of recombinant lambda gt11 fusion proteins in human cytomegalovirus diagnosis.

Authors:  A Ripalti; M P Landini; E S Mocarski; M La Placa
Journal:  J Gen Virol       Date:  1989-05       Impact factor: 3.891

8.  Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection.

Authors:  M P Landini; T Lazzarotto; A Ripalti; M X Guan; M La Placa
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

9.  Antibodies to human cytomegalovirus structural polypeptides during primary infection.

Authors:  M P Landini; E Rossier; H Schmitz
Journal:  J Virol Methods       Date:  1988-12       Impact factor: 2.014

10.  Physical and functional interaction of human cytomegalovirus DNA polymerase and its accessory protein (ICP36) expressed in insect cells.

Authors:  P F Ertl; K L Powell
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

  10 in total
  3 in total

1.  Immunological response to cytomegalovirus in congenitally infected neonates.

Authors:  J Hassan; S Dooley; W Hall
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

2.  Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens.

Authors:  R Vornhagen; B Plachter; W Hinderer; T H The; J Van Zanten; L Matter; C A Schmidt; H H Sonneborn; G Jahn
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

3.  Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteins.

Authors:  J van Zanten; M C Harmsen; M van der Giessen; W van der Bij; J Prop; L de Leij; T H The
Journal:  Clin Diagn Lab Immunol       Date:  1995-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.